Ascendis Pharma A/S

NASDAQ: ASND · Real-Time Price · USD
197.97
5.93 (3.09%)
At close: Aug 15, 2025, 3:59 PM
200.00
1.03%
After-hours: Aug 15, 2025, 06:18 PM EDT

Ascendis Pharma A/S Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-94.63M -38.47M -99.2M -109.38M -131.03M -86.88M -162.22M -121.43M -110.91M -207.42M -168.96M -81.32M -125.5M -106.06M -80.35M -134.37M -62.79M
Depreciation & Amortization
4.54M 4.47M 4.37M 4.39M 4.48M 4.98M 4.74M 4.64M 4.55M 4.64M 4.51M 4.39M 4.42M 4.27M 3.78M 3.62M 3.71M
Stock-Based Compensation
25.56M 26.22M 25.96M 26M 17.28M 15.91M 17.18M 19.88M 13.69M 13.87M 13.54M 16.8M 19.97M 14.15M 13.29M 16.32M 23.08M
Other Working Capital
-5.52M 110.58M -2.91M -2.85M 6.13M 22.53M 6.7M -11.55M -19.89M 1.17M 12.21M -7.01M -11.81M -9.94M -17.65M -17.43M 16.25M
Other Non-Cash Items
-44.84M -36.09M -85K 41.89M 48.82M 32.94M 38.97M -21.23M -29.68M 50.23M 27.34M -57.91M -1.07M -5.48M -16.59M 16.73M -61.67M
Deferred Income Tax
n/a 1.08M 1.02M n/a 2.51M 5.79M 645K -429K 1.3M 5.35M -167K -46K 241K -114K 6K -68K -191K
Change in Working Capital
95.05M -44.39M 11.79M -24.21M -51.84M -15.21M -24.03M -34.56M -25.98M -8.36M 24.9M -6.32M -28.84M -30.08M -17.65M -17.43M 16.25M
Operating Cash Flow
-14.31M -87.18M -56.13M -61.31M -101.58M -42.47M -124.72M -153.13M -147.04M -141.69M -98.83M -124.39M -130.79M -123.31M -97.52M -115.2M -81.62M
Capital Expenditures
-703K -383K -503K -342K -199K 63K -976K -444K -1.08M -3.78M -3.16M -3.73M -3.82M -4.8M -11.3M -3.58M -4.55M
Cash Acquisitions
n/a n/a n/a n/a n/a 4.28K 47.34K n/a n/a 9.47M -298.38K 5.9M 3.85M n/a n/a n/a -10.19M
Purchase of Investments
n/a n/a n/a n/a n/a -4.28K -47.34K n/a n/a -53M -71.14M -63.39M -26.31M -138.49M -11.19M -36.91M -39.44M
Sales Maturities Of Investments
n/a -1K n/a n/a 7.35M 6.58M 23.15M 47.4M 211.73M 55.99M 88.4M 71.26M 64.88M 31.37M 42.91M 51.53M 24.07M
Other Investing Acitivies
n/a 36K -36K 950K 7.35M 5K 46K 47.4M 211.73M -9.47M 298.38K -163.46K 3.79M -107.13M 31.73M 14.62M -26.09M
Investing Cash Flow
-703K -384K -503K 608K 7.16M 6.65M 22.22M 46.96M 210.65M -797K 14.1M 9.89M 38.54M -111.92M 20.43M 11.04M -30.12M
Debt Repayment
-3.07M -2.95M 131.35M -2.82M -2.79M -6.26M 137.16M -2.52M -2.57M -1.78M -1.41M -2.39M 502.5M -1.54M -1.51M -1.41M -1.96M
Common Stock Repurchased
-28.79M n/a n/a n/a n/a -1.81M n/a n/a n/a -2K 1K -150K -105.15M -21.61M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
13.83M -16.26M 296.53M 365K 21.21M 206K 6.19M 208K 1.87M 3.13M 1.34M 301K 385K 2.33M 4.43M 2.8M 1.98M
Financial Cash Flow
-18.02M 87K 427.87M -2.46M 18.42M -6.05M 143.36M -2.31M -702K 1.35M -76K -2.23M 397.74M -20.63M 370.61M 1.39M 20K
Net Cash Flow
-41.62M -65.97M 366.82M -61.54M -71.92M -49.1M 47.05M -107.06M 56.51M -163.56M -64.06M -83.26M 309.38M -246.67M 308.4M -110.51M -89.47M
Free Cash Flow
-15.02M -87.56M -56.63M -61.65M -101.78M -42.41M -125.69M -153.57M -148.13M -145.47M -102M -128.12M -134.61M -128.11M -108.82M -118.78M -86.17M